Resources for Researchers

NIAID offers many resources to support your research, including reagents, model organisms, and tissue samples, to name just a few. Use the filters under Filter Search Results to narrow your search, or simply enter specific search terms in the search field.

We found 21 resources that match your search and filter choices.
Your selections:
Clear all

Show Filters

  • Preclinical Models of Infectious Disease

    Services are provided to study the full range of pathogens, including bacteria, viruses, parasites, fungi, and other agents such as toxins and prion proteins....

    coanstevensje@nih.gov - 2017-08-22 17:18

  • HIV Drug Formulation Development and Manufacturing Services

    This service program supports the development and manufacture, of a wide variety of pharmaceutical dosage formulations, including tablets, capsules, semi-solid preparations, injectibles, and sustained-release products. If requested, manufacturing can be done under GMP....

    coanstevensje@nih.gov - 2017-08-28 15:27

  • HIV/TB Drug Development: Chemical Synthesis

    This service provides chemical synthesis of lead compounds for use in additional drug development studies. Compounds must previously have been successfully synthesized to be candidates for this service. Synthesis of new analogs is not supported....

    coanstevensje@nih.gov - 2017-08-28 15:27

  • Biopharmaceutical Product Development Services

    Provides services to facilitate preclinical development of materials that are derived from biotechnology processes, such as: Monoclonal antibodies and derivatives of monoclonal antibodies Recombinant proteins Peptides Nucleic acid based vectors (siRNA, plasmids) Live, modified-live and/or attenuated...

    coanstevensje@nih.gov - 2017-08-29 17:42

  • In Vitro Assessment for Antimicrobial Activity Program

    The In Vitro Assessment for Antimicrobial Activity program tests antimicrobial activity of products against microbial pathogens and vectors, including those derived from clinical specimens....

    coanstevensje@nih.gov - 2017-08-30 12:45

  • Interventional Agent Development Services

    The Interventional Agent Development Services program provides services to facilitate preclinical development of therapeutics and new in vivo diagnostics for infectious disease-causing pathogens and/or toxins, such as imaging and skin test reagents. Note: Devices are excluded. Part of the...

    coanstevensje@nih.gov - 2017-08-30 12:45

  • HIV Drug Development: In Vitro Efficacy Evaluations

    This service provides follow-up studies of products which already have been evaluated in a biochemical or cell-based assay and shown to possess an activity profile that warrants further development of the product as an HIV therapeutic....

    coanstevensje@nih.gov - 2017-08-30 12:45

  • Phase I Clinical Trial Units for Therapeutics

    The Phase I Clinical Trial Units for Therapeutics support the design, development, implementation, and conduct of Phase I clinical trials to assess safety, pharmacokinetics, and/or pharmacodynamics of licensed and investigational therapeutic products, including immunomodulatory agents and monoclonal...

    coanstevensje@nih.gov - 2017-08-30 19:13

  • International Epidemiologic Database to Evaluate AIDS Data Exchange Standard (IeDEA DES)

    A common data model for sharing observational HIV data has been developed by the International epidemiology Databases to Evaluate AIDS (IeDEA). The IeDEA DES is used by the seven operational regions of IeDEA to exchange data with each other for collaborative research studies. The IeDEA DES...

    coanstevensje@nih.gov - 2017-09-08 14:17

  • Vaccine and Treatment Evaluation Units (VTEUs) Services

    The Vaccine and Treatment Evaluation Units (VTEUs), supported by the Division of Microbiology and Infectious Diseases (DMID) since the 1960s, comprise a consortium of contracts with academic centers and organizations that provides a ready resource for the conduct of clinical trials to evaluate...

    coanstevensje@nih.gov - 2017-09-08 14:17

  • Biocontainment Laboratory: Duke University School of Medicine, Duke Human Vaccine Institute

    The Duke University School of Medicine, Duke Human Vaccine Institute (DHVI) Regional Biocontainment Lab (RBL) is one of the NIAID-supported Biocontainment Laboratories. The RBL supports basic research to develop drugs, diagnostics, and vaccines for emerging and reemerging infections and biodefense.

    coanstevensje@nih.gov - 2017-09-20 11:26

  • Biocontainment Laboratory: University of Chicago Howard T. Ricketts Laboratory

    The University of Chicago Howard T. Ricketts Laboratory (HTRL) is one of the NIAID-supported Biocontainment Laboratories.  The HTRL is a state of the art BSL-3 facility constructed to support research on bacterial and viral pathogens. The Lab is registered with the US Select Agent Program and its...

    coanstevensje@nih.gov - 2017-09-20 11:26

  • Biocontainment Laboratory: University of Louisville Center for Predictive Medicine (CPM)

    The Regional Biocontainment Lab (RBL) at the Center for Predictive Medicine is one of the NIAID-supported Biocontainment Laboratories. The Lab provides a valuable national resource and asset to the University of Louisville, our region, and the greater scientific and public health communities. The...

    coanstevensje@nih.gov - 2017-09-20 11:26

  • Biocontainment Laboratory: University of Missouri Regional Laboratory for Infectious Disease Research (LIDR)

    The University of Missouri Laboratory for Infectious Disease Research (LIDR) is one of the NIAID-supported Biocontainment Laboratories. LIDR is a critical resource for University of Missouri faculty and collaborating scientists who perform research on infectious diseases and is part of our...

    coanstevensje@nih.gov - 2017-09-20 11:26

  • Biocontainment Laboratory: University of Pittsburgh

    The University of Pittsburgh Regional Biocontainment Laboratory is one of the NIAID-supported Biocontainment Laboratories. The Lab is a unique facility designed to support the research community and national biodefense network by providing state-of-the-art Biosafety Level 3 (BSL-3) and Animal...

    coanstevensje@nih.gov - 2017-09-20 11:26

  • Biocontainment Laboratory: Boston University National Emerging Infectious Diseases Laboratory

    The National Emerging Infectious Diseases Laboratories (NEIDL) is part of a national network of secure facilities studying infectious diseases that are—or have the potential to become—major public health concerns...

    coanstevensje@nih.gov - 2017-10-11 13:36

  • Biocontainment Laboratory: George Mason University National Center for Biodefense and Infectious Diseases

    The George Mason University National Center for Biodefense and Infectious Diseases Biomedical Research Laboratory (BRL) is one of the NIAID-supported Biocontainment Laboratories. The RBL supports research programs in the National Center for Biodefense and Infectious Diseases focusing on host...

    coanstevensje@nih.gov - 2017-10-11 13:36

  • Biocontainment Laboratory: Rutgers University

    The Rutgers University Regional Biocontainment Laboratory is one of the NIAID-supported Biocontainment Laboratories. The RBL is a highly secure facility designed to provide an ultra-safe work environment for scientists and support staff, as well as the public at large....

    coanstevensje@nih.gov - 2017-10-11 13:36

  • Biocontainment Laboratory: Tulane University

    The Tulane University Regional Biosafety Laboratory (RBL) at The Tulane National Primate Research Center is one of the NIAID-supported Biocontainment Laboratories. Research conducted in the facility focuses on the development of treatments, vaccines and diagnostics for emerging infectious diseases...

    coanstevensje@nih.gov - 2017-10-11 13:36

  • Biocontainment Laboratory: University of Texas Medical Branch Galveston National Laboratory

    As one of two National Biocontainment Laboratories constructed under grants awarded by the National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH), the Galveston National Laboratory (GNL) enables progress in our understanding of the fundamental mechanisms...

    coanstevensje@nih.gov - 2017-10-11 13:36

  • Therapeutic Development Services

    The Therapeutic Development Services program offers a collection of preclinical services to support the development of products intended for use in the cure, mitigation, diagnosis, or treatment of disease caused by a pathogen or certain toxins....

    coanstevensje@nih.gov - 2017-11-17 16:28